GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » International Isotopes Inc (OTCPK:INIS) » Definitions » 5-Year ROIIC %

INIS (International Isotopes) 5-Year ROIIC % : -330.61% (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is International Isotopes 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. International Isotopes's 5-Year ROIIC % for the quarter that ended in Dec. 2023 was -330.61%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for International Isotopes's 5-Year ROIIC % or its related term are showing as below:

INIS's 5-Year ROIIC % is ranked worse than
97.16% of 950 companies
in the Drug Manufacturers industry
Industry Median: 3.5 vs INIS: -330.61

International Isotopes 5-Year ROIIC % Historical Data

The historical data trend for International Isotopes's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Isotopes 5-Year ROIIC % Chart

International Isotopes Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
5-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.78 16.73 62.65 76.24 -330.61

International Isotopes Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -330.61 - - -

Competitive Comparison of International Isotopes's 5-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, International Isotopes's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Isotopes's 5-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, International Isotopes's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where International Isotopes's 5-Year ROIIC % falls into.



International Isotopes 5-Year ROIIC % Calculation

International Isotopes's 5-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( -0.776 (Dec. 2023) - -0.29 (Dec. 2018) )/( 12.38 (Dec. 2023) - 12.233 (Dec. 2018) )
=-0.486/0.147
=-330.61%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


International Isotopes  (OTCPK:INIS) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


International Isotopes 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of International Isotopes's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


International Isotopes Business Description

Traded in Other Exchanges
N/A
Address
4137 Commerce Circle, Idaho Falls, ID, USA, 83401
International Isotopes Inc manufactures a full range of nuclear medicine calibration and reference standards, cobalt teletherapy sources, and other sealed sources. International Isotopes also distributes a varied selection of radioisotopes and radiochemicals for medical and clinical research, and pharmacy compounding. International Isotopes's business consists of four business segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Fluorine Products. Geographically, it generates the majority of its revenue from the United States.
Executives
W Matthew Cox officer: Chief Financial Officer C/O INTERNATIONAL ISOTOPES INC., 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Shahe Bagerdjian officer: President 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Christopher G Grosso director, 10 percent owner C/O KERSHNER GROSSO & CO, 480 BROADWAY, SARASOTA SPRINGS NY 12866
Robert Atcher director 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Laurie Mckenzie-carter officer: Chief Financial Officer 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Steve Laflin director, officer: Pres. & CEO 1258 E AIRPORT ROAD, BLACKFOOT ID 83221
William W Nicholson 10 percent owner 121 NORTH POST OAK LANE STE 2105, HOUSTON TX 77024
Ralph M Richard director, 10 percent owner 350 SHORE DRIVE, OAKDALE NY 11769
John M Mccormack 10 percent owner 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Walter D Ohearn other: Part of 13D group 1115 5TH AVENUE, NEW YORK NY 10128
Keane Marie C & Keane James Jtwros 10 percent owner